• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Student Innovation Award

Established in 2023, the Student Innovation Award aims to raise awareness of ALS/MND within the global student community. It offers students a platform to showcase creative ideas that improve the quality of life for people living with ALS/MND and helps spark innovation in the field.

To be considered for the award, candidates must:

  • Be a full-time student or part of a student team
  • Have initiated and implemented a project that has the potential for international impact
  • Present an idea that is both innovative and grounded in the real needs of people living with ALS/MND
  • Demonstrate that the solution is both practical and accessible

The winning individual or team will receive a £1,000 honorarium.

The award is presented annually during the Alliance Meeting. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15. 

Student Innovation Award Nomination

  • (No self-nominations please)
  • Drop files here or
    Max. file size: 128 MB.
    • Please include sources or credits if they apply.
    • Drop files here or
      Max. file size: 128 MB.

       

      Primary Sidebar

      • H. Todd Kelly, USA

        H. Todd Kelly, USA

      • Claudette Sturk, Canada

        Claudette Sturk, Canada
        Picture2

      • Andrew Langat, Kenya

        Andrew Langat, Kenya

      • Shaleen Latchman, Canada

        Shaleen Latchman, Canada

      • Cassio Fernando da Silva, Brazil

        Cassio Fernando da Silva, Brazil

      • Jason Goodman, USA

        Jason Goodman, USA

      • Barry de Reuver, Netherlands

        Barry de Reuver, Netherlands

      • Eddy LeFrançois, Canada

        Eddy LeFrançois, Canada

      • Margarita Pizarro, Argentina

        Margarita Pizarro, Argentina

      • Liam Dwyer, England

        Liam Dwyer, England

      • Imelda Arenas, Colombia

        Imelda Arenas, Colombia

      • Lombana, Spain

        Lombana, Spain

      • Diana Fernandez, Argentina

        Diana Fernandez, Argentina

      • Jose Rivero Muñoz, Mexico

        Jose Rivero Muñoz, Mexico

      • Jon Newsome, USA

        Jon Newsome, USA

      • Alejandro Aquino, Argentina

        Alejandro Aquino, Argentina

      • Maria Santos Garcia Tellez, Mexico

        Maria Santos Garcia Tellez, Mexico

      • Wendy Hendrickson, USA

        Wendy Hendrickson, USA

      • Anderson Custodio Pinto, Brazil

        Anderson Custodio Pinto, Brazil

      • Anna Barrow, UK

        Anna Barrow, UK

      • Fabio Carvalho, Brazil

        Fabio Carvalho, Brazil

      • Steven Spencer, New Zealand

        Steven Spencer, New Zealand

      • Willi Klein, UK

        Willi Klein, UK

      • Inta Grubb, Australia

        Inta Grubb, Australia

      • Paul Launer, USA

        Paul Launer, USA

      • Yolanda Armendariz, Mexico

        Yolanda Armendariz, Mexico

      • Eric Von Schaumburg, USA

        Eric Von Schaumburg, USA

      • Mike Cels, Canada

        Mike Cels, Canada

      • Den Haag, Netherlands

        Den Haag, Netherlands

      • Lachlan Terry, Australia

        Lachlan Terry, Australia

      • Bob Spurrier, USA

        Bob Spurrier, USA

      • Chen Chun-Chin, Malaysia

        Chen Chun-Chin, Malaysia

      • Leon Ryba, Argentina

        Leon Ryba, Argentina

      • Kirsty Gerlach, New Zealand

        Kirsty Gerlach, New Zealand

      • Eddy Lefrancois, Canada

        Eddy Lefrancois, Canada

      • Ada Garrido Benavidez, Mexico

        Ada Garrido Benavidez, Mexico

      • Emilienne Verhaegen, Belgium

        Emilienne Verhaegen, Belgium

      • Roxana Canova, Argentina

        Roxana Canova, Argentina

      • Ching-Liang Chu, Taiwan

        Ching-Liang Chu, Taiwan

      • Dr. Janmejay Pradhan, India

        Dr. Janmejay Pradhan, India

      • Claudia Cominetti, Italy

        Claudia Cominetti, Italy

      • Elisabeth Zahnd, Switzerland

        Elisabeth Zahnd, Switzerland

      • Olga Cosentino, Argentina

        Olga Cosentino, Argentina

      • Guido De Mets, Belgium

        Guido De Mets, Belgium

      • Chih Ching Darren Wong, Malaysia

        Chih Ching Darren Wong, Malaysia

      • Jose Espinosa, Argentina

        Jose Espinosa, Argentina

      • Ann Nicol, USA

        Ann Nicol, USA

      • Susan Anderson, USA

        Susan Anderson, USA

      • Gudjon Sigurdsson, Iceland

        Gudjon Sigurdsson, Iceland

      • Yessenia Hernandez Mendoza, Mexico

        Yessenia Hernandez Mendoza, Mexico

      Learn more about the March of Faces

      Footer

      Stay connected to the global ALS/MND community.

      Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

       
      This field is for validation purposes and should be left unchanged.
      • Email
      • Facebook
      • LinkedIn
      • Twitter
      • YouTube
      Return to top of page

      Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

      Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


      Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login